NAI partners with Barentz to distribute CarnoSyn in Brazil
Natural Alternatives International, Inc. recently announced it has named Barentz as the exclusive distributor of its CarnoSyn beta-alanine for the Brazilian dietary supplements market.
Archives for February 26, 2024
PLT targets restorative sleep with botanical blend for aches and pains
Ingredient supplier PLT Health Solutions has entered the sleep category with its new Serezin-branded botanical formula, designed to provide fast-acting pain relief for more restful nights and upbeat days.
Studies show gut microbiome influences ovarian aging
Mounting evidence suggests a bidirectional relationship between the gut and ovarian aging, according to Chinese researchers who reviewed studies linking the gut microbiota to ovarian function.
Deadline for entry is March 22, 2024!
Got groundbreaking microbiome-related research to shout about? We want to hear from you!
Are you researching the latest state-of-the-art developments related to prebiotic, probiotic, postbiotic and microbiome science relevant to human health, well-being, consumers and industry? If so, we would like to hear from you!
Why is Joel Freeman so successful? It’s simple.
No longer bound to limited DVD disc space, BODi super trainer Joel Freeman said he’s enjoying the wide open opportunities that his streaming platform offers. But while technology advances, one thing remains the same: simplicity.
Lutemax Kids improves dynamic visual and cognitive performance in children: Study
Natural ingredients supplier OmniActive has released findings from a six-month study supporting the benefits of its eye and brain health ingredient in preadolescent children.
DuelFuel sends warning to functional food firms after tax tribunal defeat
‘Performance flapjack’ brand DuelFuel is warning the functional foods market of potential VAT challenges after its business was devastated when made to sell its products as confectionery due to its health ingredients, making it subject to 20% VAT.
Probiotics may improve vaginal microbiota in postmenopausal women
A specific combination of probiotic strains may restore vaginal microbiota and relieve vaginal distress in postmenopausal women, according to a new study from Italian probiotic manufacturer SynBalance.
規制の見直し：韓国のビタミンC規制、中国の健康食品申請、日本のGMP
このNutra規制ラウンドアップでは、韓国におけるビタミンC健康機能性食品の注意書きに関する最新の規制発表、中国の健康食品原料ディレクトリへのアメリカ人参、高麗人参、霊芝追加、日本の健康食品事業者向けGMPガイドライン、その他について見ていきます。
「バイオティクス」ラウンドアップ：中国のポストバイオティクス基準の計画、香港のプロバイオティクス規制の要請など
このまとめでは、アジア太平洋地域のプレバイオティクス、プロバイオティクス、ポストバイオティクスにまたがる急成長中の「バイオティクス」分野における最新の出来事を追っています。
テックレビュー： 食品・栄養新製品開発のための人工知能とチャットGPTの限界
人工知能（AI）とデジタル技術が食品・栄養関連企業によってますます活用されるようになる中、このラウンドアップでは、Insilico Medicine、SRW Medicine、Yiliがどのように新製品開発にAIを活用しているか、またChatGPTのようなツールの背後にある限界は何かなど、アジア太平洋地域で起きている最新の出来事について見ていきます。
トレンドトラッカー：インドネシアのニュートラ市場、プロバイオティクスに関するグーグル検索などの分析
今回は、eコマース、ライフスタイル形式がインドネシアの栄養補助食品市場の成長を促進する方法、Googleでのプロバイオティクス検索トレンドの分析、価格とマルチヘルスの利点が栄養補助食品を購入する消費者の決定に影響を与える重要な要因であることなど、アジア太平洋地域の最新の栄養補助食品トレンドをまとめています。
ジャパン フォーカス：Daiken Biomedicalの日本特許、ビフィドバクテリウム ブレーべの効果、明治とアルビオンの協業、CUREのデビュー
Daiken Biomedicalの日本特許、プロバイオティクス菌株ビフィドバクテリウム ブレーベM-16Vのポジティブな効果、明治とアルビオンの協業開始、朝日が資金提供した酵母マンナンの研究、CBDブランドCUREの日本デビュー計画などを取り上げます。
Ashwagandha warning: Australian officials issue safety advisory, highlight risks of unregulated, overseas products
Australian regulators have warned of the risks of purchasing supplements from overseas in its latest safety advisory for products containing Ashwagandha (Withania somnifera).
Danone CEO: China’s business ‘extremely strong’ with infant, medical nutrition sales growing
Danone’s CEO says that its business in China has been “extremely strong” in FY23 with growth propelled by its specialised nutrition portfolio, which consists of infant and medical nutrition products.
Japan focus: Daiken Biomedical’s Japanese patent, B. breve benefits, Meiji and Albion’s collaboration, CURE’s debut
This round-up features Daiken Biomedical’s Japanese patent, positive effects of probiotic strain Bifidobacterium breve M-16V, Meiji and Albion’s collaborative launch, Asahi-funded study on yeast mannan, and CBD brand CURE’s Japan debut plans.